InvestorPlace - Stock Market News, Stock Advice & Trading TipsLast week's tech chaos explained... why Alphabet and Amazon's spending shocked Wall Street... the Stage 1 to Stage 2 transition... which stocks face existential threat from AI... and how Louis and Luke are positioning for the winnersThe post Why the Mag 7 Lost $950B in One Week appeared first on InvestorPlace.
Surrozen (NASDAQ:SRZN – Get Free Report) and Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation. Risk and Volatility Surrozen has a beta of 0.58, [...]
SunOpta (NASDAQ:STKL – Get Free Report) and TreeHouse Foods (NYSE:THS – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk. Analyst Ratings This is a breakdown of [...]
Altisource Portfolio Solutions (NASDAQ:ASPS – Get Free Report) and MFA Financial (NYSE:MFA – Get Free Report) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk. Insider & Institutional Ownership 41.4% of [...]
Portage Biotech (NASDAQ:ATON – Get Free Report) is one of 457 public companies in the “Pharmaceutical Preparations” industry, but how does it compare to its competitors? We will compare Portage Biotech to similar companies based on the strength of its dividends, risk, earnings, valuation, profitability, analyst recommendations and institutional ownership. Volatility and Risk Portage Biotech [...]
Oncocyte (NASDAQ:IMDX – Get Free Report) and Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) are both manufacturing companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, risk, institutional ownership and earnings. Insider and Institutional Ownership 55.3% of Oncocyte shares are [...]
%2FAlphabet%2520(Google)%2520Image%2520by%2520Markus%2520Mainka%2520via%2520Shutterstock.jpg)
Alphabet's aggressive investment in AI is already translating into tangible business momentum.
Humacyte remains rated Hold despite a DoD funding catalyst revealed today, as commercial traction for Symvess is not yet proven. Click for my HUMA stock update.
He said in a social media post that the index will double in the next three years because of his tariffs.
The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.
Richard Samans on why tariffs won’t fix global imbalances and why Europe may be best positioned to lead a bold G3 solution with the U.S. and China.
Ether’s slump is part of a broader souring of sentiment across cryptocurrency markets